Test Price
2,800 AED✅ Home Collection Available
COL1A2 Gene Osteogenesis Imperfecta Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين COL1A2 لمرض تكون العظم الناقص في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي 2026
Executive Summary & Clinical Assurance
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via NGS (Next Generation Sequencing) processed through ISO 9001:2015 accredited laboratory (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy services across all Emirates.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation provided by DHA-licensed clinical specialists.
Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731
Overview: COL1A2 NGS Genetic DNA Analysis
The COL1A2 gene encodes the alpha-2 chain of type I collagen, a critical structural protein in bone, skin, tendons, and connective tissues. Pathogenic variants in COL1A2 are causally linked to Osteogenesis Imperfecta (OI), a heritable connective tissue disorder characterized by bone fragility, skeletal deformities, and in certain subtypes, dentinogenesis imperfecta and blue sclerae. This NGS-based test provides comprehensive sequencing of the COL1A2 gene to identify single nucleotide variants, small insertions/deletions, and splice-site mutations with clinical-grade precision.
يُعد جين COL1A2 مسؤولاً عن إنتاج سلسلة ألفا-2 من الكولاجين من النوع الأول، وهو بروتين هيكلي أساسي في العظام والجلد والأنسجة الضامة. ترتبط الطفرات المرضية في هذا الجين بمرض تكون العظم الناقص، مما يجعل هذا الفحص أداة تشخيصية حاسمة للتخطيط الطبي والوراثي.
| Parameter | Our Test (Premium NGS Panel) | Closest Alternative (Standard PCR Panel) |
|---|---|---|
| Diagnostic Precision | 99.9% — Full gene sequencing via NGS with >200x read depth | ~85-90% — Targeted mutation hotspot analysis only; misses rare/novel variants |
| Methodology | Next Generation Sequencing (NGS) with bioinformatic variant interpretation per ACMG 2026 guidelines | Sanger Sequencing (single-exon resolution) or limited multiplex PCR panels |
| Turnaround Time | 3 to 4 Weeks with interim clinical update at Week 2 | 6 to 8 Weeks (standard reference lab queues) |
| Sample Flexibility | Whole Blood, Extracted DNA, or One Drop Blood on FTA Card | Venous whole blood only; requires refrigerated transport within 24h |
| Pre-Test Genetic Counselling | Included — Comprehensive pedigree charting and risk assessment | Typically not included; separate referral required |
| Price (AED) | 2800 AED | 2200–3200 AED (variable, often excluding counselling) |
Physician Insight & Clinical Correlation
"As a clinician with decades of experience in genetic diagnostics, I always emphasize that a COL1A2 variant report is not a standalone verdict — it is a starting point for a lifelong, multidisciplinary care plan. This test identifies the molecular lesion, but the clinical phenotype of Osteogenesis Imperfecta varies widely; please ensure you interpret these results alongside a complete skeletal survey, family history, and specialist consultation. I urge every patient and family to view this genetic insight as empowering, not limiting, because early intervention and coordinated orthopedic, dental, and audiological surveillance can dramatically improve quality of life."
— Dr. PRABHAKAR REDDY, DHA License: 61713011, Senior Clinical Genetic Consultant
⚠ Medication Safety Warning
Do not discontinue prescribed medication or alter any treatment plan without consulting your doctor. Genetic test results must be interpreted within the full clinical context by a DHA-licensed physician.
Safety Protocol & Exclusion Criteria
Exclusion Criteria for Home Collection
- Active febrile illness (temperature > 38.5°C) — reschedule after full recovery
- Known coagulopathy or current anticoagulant therapy without physician clearance
- Severe anemia (Hb < 7 g/dL) or hemodynamic instability
- Patient age under 18 years without documented parental/guardian consent (per UAE CDS Law 2026 — Minors)
- Recent hematopoietic stem cell transplant or allogeneic blood transfusion within 90 days (may confound germline genetic analysis)
Emergency Red Flags — Seek Immediate Medical Attention
- Sudden severe bone pain with deformity or loss of function — potential pathological fracture
- Respiratory distress or chest wall deformity progression — may indicate vertebral compression fractures
- Acute hearing loss or tinnitus — requires urgent audiological evaluation (associated with OI)
- Signs of basilar invagination: headache, dysphagia, or cranial nerve dysfunction
Patient FAQ & Clinical Guidance
1. What does the COL1A2 Genetic Test detect, and how accurate is it compared to traditional methods?
This NGS-based test provides comprehensive full-gene sequencing of COL1A2 with 99.9% diagnostic sensitivity, detecting single nucleotide variants, small insertions/deletions, and splice-site mutations that standard PCR panels may miss entirely. Unlike targeted hotspot analysis, NGS interrogates every coding exon with high-depth coverage, ensuring that rare or novel pathogenic variants are captured and classified according to the 2026 ACMG/AMP variant interpretation framework, which significantly outperforms older Sanger-based limited-exon approaches in both breadth and clinical yield.
2. What sample types are accepted, and how should I prepare for the test?
We accept three sample types for maximum patient convenience: (1) Whole Blood collected in EDTA tubes via standard venipuncture, (2) Previously Extracted DNA at a minimum concentration of 50 ng/µL, or (3) One Drop of Blood on an FTA Card — an especially useful option for pediatric patients, patients in remote Emirates, or situations where immediate cold-chain transport is unavailable. Before sample collection, all patients must complete a Genetic Counselling session wherein a detailed three-generation pedigree chart is drawn to document family members affected by COL1A2-related Osteogenesis Imperfecta or connective tissue disorders, as this clinical history is essential for accurate variant interpretation and risk stratification.
3. هل يغطي التأمين الصحي تكلفة فحص جين COL1A2 في الإمارات؟ (Does health insurance cover the COL1A2 gene test in the UAE?)
نعم، العديد من خطط التأمين الصحي في الإمارات تغطي الفحوصات الجينية التشخيصية مثل فحص جين COL1A2 لمرض تكون العظم الناقص، خاصة عند وجود إحالة طبية من طبيب مختص معتمد من هيئة الصحة بدبي. يمكن لفريقنا التحقق من تغطية التأمين مباشرة عبر واتساب على الرقم +971 54 548 8731 قبل إجراء الفحص.
Yes, many UAE health insurance plans cover diagnostic genetic testing such as the COL1A2 NGS analysis for Osteogenesis Imperfecta, particularly when accompanied by a DHA-licensed specialist referral. We offer direct pre-test insurance verification — simply message us on WhatsApp at +971 54 548 8731 with your insurer details, and our billing team will confirm your coverage status, co-payment obligations, and any pre-authorization requirements within one business day.
Regulatory & Accreditation Compliance
This diagnostic service is fully compliant with Federal Decree-Law No. 41 of 2024 (Article 87) governing genomic testing in the UAE, the UAE PDPL (Personal Data Protection Law) for genetic data privacy, and the 2026 CDS Law provisions regarding genetic testing in minors (parental/guardian consent mandatory). Our laboratory operates under ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139), DHA Facility License No. 9834453, and follows the 2026 ACMG technical standards for clinical NGS variant interpretation. All patient genetic data is stored on encrypted, UAE-sovereign servers in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection.
Schedule Your COL1A2 Genetic
Home Collection Available 8 AM – 11 PM | TAT: 3–4 Weeks | 2800 AED
WhatsApp: +971 54 548 8731
DHA Facility License: 9834453 | ISO 9001:2015 (INT/EGQ/2509DA/3139)
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians